482 related articles for article (PubMed ID: 25562451)
1. Antidepressant actions of ketamine: from molecular mechanisms to clinical practice.
Monteggia LM; Zarate C
Curr Opin Neurobiol; 2015 Feb; 30():139-43. PubMed ID: 25562451
[TBL] [Abstract][Full Text] [Related]
2. NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research.
Lv S; Yao K; Zhang Y; Zhu S
Neuropharmacology; 2023 Mar; 225():109378. PubMed ID: 36539011
[TBL] [Abstract][Full Text] [Related]
3. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
Kavalali ET; Monteggia LM
Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
[TBL] [Abstract][Full Text] [Related]
4. Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression.
Drewniany E; Han J; Hancock C; Jones RL; Lim J; Nemat Gorgani N; Sperry JK; Yu HJ; Raffa RB
J Clin Pharm Ther; 2015 Apr; 40(2):125-30. PubMed ID: 25545040
[TBL] [Abstract][Full Text] [Related]
5. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.
Krystal JH; Sanacora G; Duman RS
Biol Psychiatry; 2013 Jun; 73(12):1133-41. PubMed ID: 23726151
[TBL] [Abstract][Full Text] [Related]
6. The rapid-onset antidepressant effect of ketamine: More surprises?
Raffa RB; Pergolizzi JV; Taylor R;
J Clin Pharm Ther; 2018 Apr; 43(2):308-311. PubMed ID: 29178131
[TBL] [Abstract][Full Text] [Related]
7. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
Suzuki K; Monteggia LM
Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
[TBL] [Abstract][Full Text] [Related]
8. Ketamine for Treatment-Resistant Depression: a New Advocate.
Pérez-Esparza R
Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
[TBL] [Abstract][Full Text] [Related]
9. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms.
Krystal JH; Kavalali ET; Monteggia LM
Neuropsychopharmacology; 2024 Jan; 49(1):41-50. PubMed ID: 37488280
[TBL] [Abstract][Full Text] [Related]
10. Targeting metaplasticity mechanisms to promote sustained antidepressant actions.
Brown KA; Gould TD
Mol Psychiatry; 2024 Apr; 29(4):1114-1127. PubMed ID: 38177353
[TBL] [Abstract][Full Text] [Related]
11. The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways.
Ren L
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110910. PubMed ID: 38061484
[TBL] [Abstract][Full Text] [Related]
12. Ketamine - a long way from anesthetic to a prototype antidepressant: Review of potential mechanisms of action.
Pochwat B
Psychiatr Pol; 2022 Oct; 56(5):1017-1032. PubMed ID: 37074854
[TBL] [Abstract][Full Text] [Related]
13. [Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression].
Gosek P; Chojnacka M; Bieńkowski P; Swiecicki Ł
Psychiatr Pol; 2012; 46(2):283-94. PubMed ID: 23214398
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of ketamine and its metabolites as antidepressants.
Hess EM; Riggs LM; Michaelides M; Gould TD
Biochem Pharmacol; 2022 Mar; 197():114892. PubMed ID: 34968492
[TBL] [Abstract][Full Text] [Related]
15. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
Kato T; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172827. PubMed ID: 31733218
[TBL] [Abstract][Full Text] [Related]
16. Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.
Gerhard DM; Wohleb ES; Duman RS
Drug Discov Today; 2016 Mar; 21(3):454-64. PubMed ID: 26854424
[TBL] [Abstract][Full Text] [Related]
17. Ketamine and magnesium common pathway of antidepressant action.
Górska N; Cubała WJ; Słupski J; Gałuszko-Węgielnik M
Magnes Res; 2018 May; 31(2):33-38. PubMed ID: 30398153
[TBL] [Abstract][Full Text] [Related]
18. Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants.
Kato T
Neuropharmacology; 2023 Feb; 223():109325. PubMed ID: 36334763
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.
Aleksandrova LR; Phillips AG; Wang YT
J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212
[TBL] [Abstract][Full Text] [Related]
20. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
